Washington Trust CO Pfizer Inc Transaction History

Washington Trust CO

$2.7 Billion
Q1 2024

A detailed history of Washington Trust CO transactions in Pfizer Inc stock. As of the latest transaction made, Washington Trust CO holds 343,643 shares of PFE stock, worth $9.56 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares

343,643

Previous 346,639 0.86%

Holding current value

$9.56 Million

Previous $9.98 Million 4.44%

% of portfolio

0.35%

Previous 0.4%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 23, 2024	SELL	$25.89 - $29.73 $77,566 - $89,071	-2,996 Reduced 0.86%	343,643 $9.54 Million
Q4 2023 Jan 18, 2024	SELL	$26.13 - $33.94 $81,003 - $105,214	-3,100 Reduced 0.89%	346,639 $9.98 Million
Q3 2023 Oct 18, 2023	BUY	$32.09 - $37.51 $77,144 - $90,174	2,404 Added 0.69%	349,739 $11.6 Million
Q2 2023 Jul 27, 2023	BUY	$36.12 - $41.79 $253,887 - $293,741	7,029 Added 2.07%	347,335 $12.7 Million
Q1 2023 May 10, 2023	BUY	$39.39 - $51.28 $13.4 Million - $17.4 Million	339,797 Added 99940.29%	340,137 $13.9 Million

Q1 2023 May 04, 2023	SELL	$39.39 - $51.28 $13.4 Million - $17.4 Million	-339,966 Reduced 99.9%	340 $13.9 Million
Q4 2022 Jul 27, 2023	BUY	$41.75 - $54.5 $7,055 - $9,210	169 Added 0.05%	340,306 $17.4 Million
Q4 2022 Feb 08, 2023	SELL	$41.75 - $54.5 $435,911 - $569,034	-10,441 Reduced 2.98%	340,306 $17.4 Million
Q3 2022 Oct 14, 2022	SELL	$43.76 - $53.42 $114,607 - $139,906	-2,619 Reduced 0.74%	350,747 $15.3 Million
Q2 2022 Jul 25, 2022	BUY	$46.53 - $55.17 $169,694 - $201,204	3,647 Added 1.04%	353,366 $18.5 Million
Q1 2022 May 05, 2022	SELL	$45.75 - $56.69 $118,858 - $147,280	-2,598 Reduced 0.74%	349,719 $18.1 Million
Q4 2021 Feb 09, 2022	SELL	$41.32 - $61.25 $1.75 Million - $2.6 Million	-42,388 Reduced 10.74%	352,317 $20.8 Million
Q3 2021 Nov 09, 2021	BUY	$39.25 - $50.42 $270,589 - $347,595	6,894 Added 1.78%	394,705 $17 Million
Q2 2021 Aug 05, 2021	BUY	$35.91 - $40.68 $402,227 - $455,656	11,201 Added 2.97%	387,811 $15.2 Million
Q1 2021 Apr 28, 2021	BUY	$33.49 - $37.77 $454,023 - $512,047	13,557 Added 3.73%	376,610 $13.6 Million
Q4 2020 Feb 09, 2021	BUY	$33.47 - $42.56 $264,714 - $336,607	7,909 Added 2.23%	363,053 $13.4 Million
Q3 2020 Nov 05, 2020	BUY	$31.75 - $37.25 $498,221 - $584,527	15,692 Added 4.62%	355,144 $13 Million
Q2 2020 Aug 04, 2020	SELL	$30.12 - $36.54 $750,951 - $911,015	-24,932 Reduced 6.84%	339,452 $11.1 Million
Q1 2020 May 07, 2020	BUY	$27.03 - $38.62 $494,162 - $706,050	18,282 Added 5.28%	364,384 $11.9 Million
Q4 2019 Feb 12, 2020	BUY	$32.92 - $37.36 $1.1 Million - $1.25 Million	33,558 Added 10.74%	346,102 $13.6 Million
Q3 2019 Nov 06, 2019	BUY	$32.49 - $42.13 $333,314 - $432,211	10,259 Added 3.39%	312,544 $12 Million
Q2 2019 Aug 07, 2019	BUY	$36.98 - $41.52 $209,565 - $235,293	5,667 Added 1.91%	302,285 $13.1 Million
Q1 2019 May 13, 2019	SELL	$37.5 - $41.2 $525,187 - $577,006	-14,005 Reduced 4.51%	296,618 $12.1 Million
Q4 2018 Feb 11, 2019	SELL	$38.47 - $43.86 $468,026 - $533,600	-12,166 Reduced 3.77%	310,623 $13.6 Million
Q3 2018 Nov 13, 2018	SELL	$34.47 - $41.81 $387,408 - $469,902	-11,239 Reduced 3.36%	322,789 $14.2 Million
Q2 2018 Aug 10, 2018	BUY	$32.98 - $35.16 $1.14 Million - $1.21 Million	34,508 Added 11.52%	334,028 $12.1 Million
Q1 2018 May 10, 2018	SELL	$31.91 - $37.02 $478,841 - $555,522	-15,006 Reduced 4.77%	299,520 $10.6 Million
Q4 2017 Feb 05, 2018	BUY	$33.26 - $35.29 $798 - $846	24 Added 0.01%	314,526 $11.4 Million
Q3 2017 Oct 31, 2017	BUY	$31.0 - $34.15 $9.75 Million - $10.7 Million	314,502	314,502 $11.2 Million

Others Institutions Holding PFE

# of Institutions

3,158

Shares Held

3.68B

Call Options Held

67.4M

Put Options Held

113M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $156B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Washington Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Washington Trust CO with notifications on news.

Account

Washington Trust CO Pfizer Inc Transaction History